Stem/progenitor cell-based therapy for Duchenne muscular dystrophy

View Full Paper

Ask AI

Bookmark

Stem/progenitor cell-based therapy aims to improve muscle regeneration in patients with duchenne muscular dystrophy.
Myogenic stem/progenitor cells are expected to restore myofibers and dystrophin in muscles affected by duchenne muscular dystrophy.
Mesenchymal stem cells have immunosuppressive properties that may enhance the effects of other gene therapies in treating duchenne muscular dystrophy.
Optimizing cell transplantation conditions is critical for successfully integrating new cells into muscle tissue in duchenne muscular dystrophy.

Discussion

No takes yet. Share an insight, caveat, or question.

Review highlights how stem cell therapies aim to promote muscle regeneration in Duchenne muscular dystrophy, suggesting new treatment strategies.

Tominari et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Review highlights how stem cell therapies aim to promote muscle regeneration in Duchenne muscular dystrophy, suggesting new treatment strategies.